Ulteriori informazioni
Te rapidly changing concepts in radiation oncology with the development of more precise - strumentation for delivery of radiation therapy and a greater emphasis on hypofractionation technologies require a very intimate knowledge of tumor biology and the infuence of various biologic factors on dose distribution within the tumor in terms of homogeneity as well as prev- tion of any late efects on normal tissue surrounding the tumor itself. Not only are these major factors in clinical practice but also the known factors of inhomogeneity of cancer cells, the impact of microenvironment in terms of radiation efect, and host factors make it mandatory to design therapeutic strategies to improve the outcome and to diminish any potential short-term or lo- term risks from the radiation therapy. Te authors have developed an outstanding text that deals with these strategies and how they would impact on established and emerging new technologies and treatment. Te context of the presentations within a multidisciplinary combined modality therapy program is incredibly - portant. In this volume, various topics are reviewed including tumor genesis, cell proliferation, - giogenesis, the physiologic characteristics of malignant tissues, invasion and adhesion, the route and role pursued in the development of metastasis, and the role of the human immune system in cancer prevention and development.
Sommario
Tumorigenesis.- Tumor Growth and Cell Proliferation.- Tumor Angiogenesis.- Pathophysiology of Solid Tumors.- Adhesion, Invasion, Integrins, and Beyond.- The Biology of Cancer Metastasis.- Role of the Immune System in Cancer Development and Therapeutic Implications.- Tumor Detection by Biological Markers.- Tumor Imaging with Special Emphasis on the Role of Positron Emission Tomography in Radiation Treatment Planning.- Quantitative Cell Kill of Radio- and Chemotherapy.- The Impact of Molecularly Targeted Therapy in Multi-Modality Therapy.- Target-Based Interventions to Treat Radiation-Induced Lung Injury.- Mechanisms of Treatment Resistance: Molecular and Clinical Examples for Radio- and Chemotherapy.- DNA Repair and Cell Cycle Regulation After Ionizing Irradiation.- Physiological Mechanisms of Treatment Resistance.- Influence of Time Factor and Repopulation on Treatment Resistance.- Molecular Tools, Expression Profiling.- Strategies of Gene Transfer and Silencing, and Technical Considerations.- Tumor Biology's Impact on Clinical Cure Rates.- Dose-Escalated High-Precision Radiotherapy: a Method to Overcome Variations in Biology and Radiosensitivity Limiting the Success of Conventional Approaches?.- Treatment of the Primary Tumor in Metastatic Cancer: Influence on Outcome.
Info autore
Herr Professor Dr. Michael Molls leitet die Universitätsklinik für Strahlentherapie und radiologische Onkologie am Klinikum rechts der Isar in München.
Herr Professor Dr. Michael Molls leitet die Universitätsklinik für Strahlentherapie und radiologische Onkologie am Klinikum rechts der Isar in München.
Riassunto
Te rapidly changing concepts in radiation oncology with the development of more precise - strumentation for delivery of radiation therapy and a greater emphasis on hypofractionation technologies require a very intimate knowledge of tumor biology and the infuence of various biologic factors on dose distribution within the tumor in terms of homogeneity as well as prev- tion of any late efects on normal tissue surrounding the tumor itself. Not only are these major factors in clinical practice but also the known factors of inhomogeneity of cancer cells, the impact of microenvironment in terms of radiation efect, and host factors make it mandatory to design therapeutic strategies to improve the outcome and to diminish any potential short-term or lo- term risks from the radiation therapy. Te authors have developed an outstanding text that deals with these strategies and how they would impact on established and emerging new technologies and treatment. Te context of the presentations within a multidisciplinary combined modality therapy program is incredibly - portant. In this volume, various topics are reviewed including tumor genesis, cell proliferation, - giogenesis, the physiologic characteristics of malignant tissues, invasion and adhesion, the route and role pursued in the development of metastasis, and the role of the human immune system in cancer prevention and development.
Testo aggiuntivo
From the reviews:
“The stated aim of the editors of this book is ‘to provide the practising radiation oncologist with a concise overview of the most important and up-to-date information pertaining to tumour biology as it impacts on cancer treatment’ … useful guide to the molecular era of cancer biology and personalised cancer therapy, particularly in relation to radiation oncology. … The book would be of interest to any oncologist and would serve as a useful revision tool for the FRCR part 1 examination.” (Joe O’Sullivan, RAD Magazine, December, 2009)
Aus den Rezensionen:
“Dieses umfassende Lehrbuch erläutert alle wesentlichen Gesichtspunkte der Tumorbiologie ... Die Literaturhinweise sind umfangreich, vollständig und aktuell, sofern dies in einem Lehrbuch überhaupt möglich ist. Die Autoren sind international ausgewiesene Grundlagenwissenschaftler und klinische Krebsforscher. Die Kapitel weisen ein qualitativ hochwertiges Layout mit zahlreichen, durchgehend farbigen Bildern auf und sind gut lesbar. Das Buch stellt eine wesentliche Bereicherung der tumorbiologischen Literatur dar. Wir empfehlen es als aktuelles radiobiologisches Standardwerk.“ (Stephan Roth, in: Strahlentherapie und Onkologie, 1/December/2009, S. 844)
Relazione
From the reviews: "The stated aim of the editors of this book is 'to provide the practising radiation oncologist with a concise overview of the most important and up-to-date information pertaining to tumour biology as it impacts on cancer treatment' ... useful guide to the molecular era of cancer biology and personalised cancer therapy, particularly in relation to radiation oncology. ... The book would be of interest to any oncologist and would serve as a useful revision tool for the FRCR part 1 examination." (Joe O'Sullivan, RAD Magazine, December, 2009) Aus den Rezensionen: "Dieses umfassende Lehrbuch erläutert alle wesentlichen Gesichtspunkte der Tumorbiologie ... Die Literaturhinweise sind umfangreich, vollständig und aktuell, sofern dies in einem Lehrbuch überhaupt möglich ist. Die Autoren sind international ausgewiesene Grundlagenwissenschaftler und klinische Krebsforscher. Die Kapitel weisen ein qualitativ hochwertiges Layout mit zahlreichen, durchgehend farbigen Bildern auf und sind gut lesbar. Das Buch stellt eine wesentliche Bereicherung der tumorbiologischen Literatur dar. Wir empfehlen es als aktuelles radiobiologisches Standardwerk." (Stephan Roth, in: Strahlentherapie und Onkologie, 1/December/2009, S. 844)
